BCR-ABL-induced adhesion defects are tyrosine kinase-independent

Blood

Volumn 99, Issue 11, 2002, Pages 4122-4130

  Wertheim, Jason A ^a   Forsythe, Kevin ^a   Druker, Brian J ^a   Hammer, Daniel ^a   Boettiger, David ^a   Pear, Warren S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; FIBRONECTIN; IMATINIB; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; MOUSE; MYELOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

EID: 0036625016     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.11.4122     Document Type: Article

References (50)

1. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497-1499.
2. Sawyers CL. Chronic myeloid leukemia. N Engl J Med. 1999;340:1330-1340.
3. Verfaillie CM, McCarthy JB, McGlave PB. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest. 1992;90:1232-1241.
4. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF, Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature. 1987;328:342-344.
5. Bazzoni G, Carlesso N, Griffin JD, Hemler ME. Bcr/Abl expression stimulates integrin function in hematopoietic cell lines. J Clin Invest. 1996;98:521-528.
6. McWhirter JR, Wang JY. Activation of tyrosinase kinase and microfilament-binding functions of cabl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol. 1991;11:1553-1565.
7. McWhirter JR, Wang JY. An actin-binding function contributes to transformation by the Bcr-Abl onco-protein of Philadelphia chromosome-positive human leukemias. EMBO J. 1993;12:1533-1546.
8. Salgia R, Li JL, Ewaniuk DS, et al. BCR/ABL induces multiple abnormalities of cytoskeletal function. J Clin Invest. 1997;100:46-57.
9. Salgia R, Brunkhorst B, Pisick E, et al. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL. Oncogene. 1995;11:1149-1155.
10. Schofield KP, Rushton G, Humphries MJ, Dexter TM, Gallagher JT. Influence of interleukin-3 and other growth factors on alpha4beta1 integrin-mediated adhesion and migration of human hematopoietic progenitor cells. Blood. 1997;90:1858-1866.
11. Carlesso N, Griffin JD, Druker BJ. Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene. 1994;9:149-156.
12. Zhang X, Ren R. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia. Blood. 1998;92:3829-3840.
13. Hurley RW, McCarthy JB, Verfaillie CM. Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest. 1995;96:511-519.
14. van der Sluijs JP, Baert MR, Ploemacher RE. Differential adherence of murine hematopoietic stem cell subsets to fibronectin. Exp Hematol. 1994;22:1236-1243.
15. Kramer A, Homer S, Willer A, et al. Adhesion to fibronectin stimulates proliferation of wild-type and bcr/abl-transfected murine hematopoietic cells. Proc Natl Acad Sci U S A. 1999;96:2087-2092.
16. Garcia AJ, Ducheyne P, Boettiger D. Quantification of cell adhesion using a spinning disc device and application to surface-reactive materials. Biomaterials. 1997;18:1091-1098.
17. 1 integrin binding to surface-adsorbed fibronectin. J Biol Chem. 1998;273:34710-34715.
18. 1 integrin-fibronectin bonds in intact adherent cells is sensitive to integrin activation state. J Biol Chem. 1998;273:10988-10993.
19. Yung LY, Lim F, Khan MM, Kunapuli SP, Rick L, Colman RW, Cooper SL. Neutrophil adhesion on surfaces preadsorbed with high molecular weight kininogen under well-defined flow conditions. Immunopharmacology. 1996;32:19-23.
20. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE. The detachment strength and morphology of bone cells contacting materials modified with a peptide sequence found within bone slaloprotein. J Biomed Mater Res. 1997;37:9-19.
21. Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996;2:561-566.
22. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344:1031-1037.
23. Pear WS, Miller JP, Xu L, et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 1998;92:3780-3792.
24. Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci U S A. 1983;80:2931-2935.
25. Pear WS, Cepko C. Transduction of genes using retrovirus vectors. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current Protocols in Molecular Biology Supplement 36. New York, NY: Wiley; 1996: 9.9.1.
26. Ogura M, Morishima Y, Ohno R, et al. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood. 1985;66:1384-1392.
27. Sparrow EM, Gregg JL. Mass transfer, flow, and heat transfer about a rotating disk. J Heat Transfer, Trans ASME. 1960:294-302.
28. Levich VG. Physicochemical Hydrodynamics. Englewood Cliffs, NJ: Prentice Hall; 1962.
29. Cozens-Roberts C, Quinn JA, Lauffenburger DA. Receptor-mediated cell attachment and detachment kinetics, II: Experimental model studies with the radial-flow detachment assay. Biophys J. 1990;58:857-872.
30. Cozens-Roberts C, Lauffenburger DA, Quinn JA. Receptor-mediated cell attachment and detachment kinetics, I: Probabilistic model and analysis. Biophys J. 1990;58:841-856.
31. Sharma A, Askari JA, Humphries MJ, Jones EY, Stuart DI. Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J. 1999;18:1468-1479.
32. Main AL, Harvey TS, Baron M, Boyd J, Campbell ID. The three-dimensional structure of the tenth type III module of fibronectin: An insight into RGD-mediated interactions. Cell. 1992;71:671-678.
33. Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, Kuriyan J. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science. 2000;289:1938-1942.
34. Buchdunger E, Cioffi CL, Law N, et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-Kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther. 2000;295:139-145.
35. Daley GQ, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci U S A. 1988;85:9312-9316.
36. Greenberger JS. The hematopoietic microenvironment. Crit Rev Oncol Hematol. 1991;11:65-84.
37. Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett MJ, Eaves AC. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc Natl Acad Sci U S A. 1992;89:6192-6196.
38. Cozens-Roberts C, Quinn JA, Lauffenberger DA. Receptor-mediated adhesion phenomena. Model studies with the radical-flow detachment assay. Biophys J. 1990;58:107-125.
39. + cells from DNA damage-induced apoptosis. Blood. 2001;98:1532-1541.
40. Henkemeyer M, West SR, Gertler FB, Hoffmann FM. A novel tyrosine kinase-independent function of Drosophila abl correlates with proper subcellular localization. Cell. 1990;63:949-960.
41. Vigneri P, Wang JY. Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat Med. 2001;7:228-234.
42. -/- fibroblasts on fibronectin by a kinase-independent mechanism. Genes Dev. 1995;9:1505-1517.
43. Gaston I, Stenberg PE, Bhat A, Druker BJ. Abl kinase but not P13-kinase links to the cytoskeletal defects in Bcr-Abl transformed cells. Exp Hematol. 2000;28:77-86.
44. 1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors. Leukemia. 1998;12:1708-1717.
45. Wang Y, Miller AL, Mooseker MS, Koleske AJ. The Abl-related gene (Arg) nonreceptor tyrosine kinase uses two F-actin-binding domains to bundle F-actin. Proc Natl Acad Sci U S A. 2001;98:14865-14870.
46. Boettiger D, Lynch L, Blystone S, Huber F. Distinct ligand-binding modes for integrin alpha vbeta 3-mediated adhesion to fibronectin versus vitronectin. J Biol Chem. 2001;276:31684-31690.
47. Heisterkamp N, Voncken JW, Senadheera D, et al. Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants. Blood. 2000;96:2226-2232.
48. He Y, Wertheim JA, Xu L, et al. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl. Blood. 2002;99:2957-2968.
49. Zhang X, Subrahmanyam R, Worg R, Gross AW, Ren R. The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl. Mol Cell Biol. 2001;21:840-853.
50. Million RP, Van Etten RA. The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood. 2000;96:664-670.